Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elevate Health vs GoodRx

Elevate Health
Graded #371

Lower grade

vs+11.099999999999994
GoodRx
Graded #116

Higher grade

The verdict

GoodRx takes it — 69.6/100 to 58.5/100.

GoodRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGoodRx +48
32
80
Dose & formulationElevate Health +7
77
70
Clinical oversightElevate Health +10
79
69
Labs & monitoringElevate Health +12
63
51
FulfillmentGoodRx +16
65
81
Contract termsGoodRx +30
25
55
Elevate Health · left barGoodRx · right bar

The numbers

MetricElevate HealthGoodRx
WeighScore58.5/10069.6/100
GradeCC
Scorecard rank#371#116
Semaglutide$299/mo (compounded)Not disclosed
Tirzepatide$399/mo (compounded)$299/mo (brand Zepbound)
CoverageCoverage not publishedAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Elevate Health

Graded #371 · C

Strengths

  • Compounded semaglutide ($299/mo, from $158/mo on 12-month) and tirzepatide ($399/mo, from $248/mo)
  • Also offers brand-name Zepbound (tirzepatide) plus NAD+, B12, and glutathione add-ons
  • All supplies included; Affirm/Klarna payment plans available
  • Full refund if you are not approved
  • 35,000+ patients served

Where it loses points

  • Month-to-month pricing is high ($299 sema / $399 tirz); the low rates require a 12-month commitment
  • Pharmacy partner and prescribing medical group not named
  • States of operation not published
  • Not LegitScript-certified (no certification displayed)
  • No standalone Terms of Service page (only Privacy, HIPAA, and a safety-information page)
GoodRx

Graded #116 · C

Strengths

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

Where it loses points

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard